CFDA Issues Regulatory Reformation Proposal Draft on Drug Life Cycle Management:Getting Close to Western Regulations
CFDA proposes a regulation reformation draft on life cycle management: shorten the timeline for IND approval, loosen control over clinical trial sites and improve IP protection for innovative molecules.
Source: http://www.sfda.gov.cn/WS01/CL0087/172569.html